Skip to main content
logo
BridgeBio Pharma, Inc. (BBIO)
NASDAQ: BBIO · Real-Time Price · USD
79.37
-1.03 (-1.28%)
At close: Aug 26, 2026, 4:00 PM EDT
80.09
+0.72 (0.91%)
After-hours: Aug 26, 2026, 5:47 PM EDT

BridgeBio Pharma Financials Overview

Millions USD. Fiscal year is Jan - Dec.

Revenue & Profits
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Revenue
713.07502.08221.99.377.6569.72
Revenue Growth
202.39%126.26%2285.27%-88.02%11.38%745.14%
Gross Profit
673.41481.11218.026.8674.2166.6
Operating Income
-477.82-502.06-577.37-599.44-468.44-573.33
Net Income
-691.87-724.93-535.76-643.2-481.18-562.54
Earnings Per Share
-3.57-3.78-2.88-3.95-3.26-3.90
EPS Growth
------

Revenue by Segment
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023
Period EndingJun '26 Dec '25 Dec '24 Dec '23
Net Product
657.16362.372.88359.48
License and Services
21.42128.32218.85-90.53
Royalty
34.4911.390.1711.22
Revenue (Total)
713.07502.08221.99.3

Cash & Debt
Chart
Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Investments
720.16587.48681.1434.88471.92836.66
Total Debt
3,3731,8621,7311,7401,7241,726
Net Cash (Debt)
-2,653-1,275-1,049-1,305-1,252-889.51
Net Cash Growth
------
Net Cash Per Share
-13.67-6.66-5.64-8.02-8.49-6.16

Cash Flow & CapEx
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Operating Cash Flow
-434.37-445.91-520.73-527.72-419.49-497.93
Capital Expenditures
-1.02-1.1-0.93-1.31-4.82-13.25
Free Cash Flow
-435.39-447.01-521.66-529.03-424.32-511.18
Free Cash Flow Growth
------

Margins
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Gross Margin
94.44%95.83%98.25%73.71%95.58%95.53%
Operating Margin
-67.01%-100.00%-260.19%-6443.56%-603.28%-822.38%
Pretax Margin
-98.68%-145.89%-244.34%-7021.94%-624.17%-841.20%
Profit Margin
-97.03%-144.39%-241.44%-6913.92%-619.70%-806.90%
FCF Margin
-61.06%-89.03%-235.08%-5686.62%-546.46%-733.23%

Valuation
Chart
Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingAug '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PS Ratio
21.8529.3623.37754.9214.6735.22